StockData
CytoMed Therapeutics Ltd logo

CytoMed Therapeutics Ltd (GDTC) stock

GDTCNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 31, 2026Score 4/30
$0.83+0.05 (+6.00%)

Close on Nov 18, 2026Market cap $9.82MP/E –Yield –

CytoMed Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

CytoMed Therapeutics's market cap was $9.94M on Nov 11, 2026, against $21.23M a year earlier. Over the last 4 years it ranged from $9.31M to $41.38M, with a median of $24.33M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$9.94M-35.5%
2025Dec 31, 2025$15.41M-60.7%
2024Dec 31, 2024$39.20M-5.3%
2023Dec 29, 2023$41.38M–

More CytoMed Therapeutics figures

See a number that looks wrong?